Abstract:IntroductionHeart failure with preserved ejection fraction (HFpEF) is on pace to become the most common type of heart failure in the population with a prevalence that is increasing by 1% annually. Despite this, there remains no gold standard in diagnosing HFpEF. In addition to clinical exam and history, scoring criteria including H2FPEF score and HFA-PEFF score have been validated to assist in diagnosis. Guidelines and algorithms to determine echocardiographic diastolic dysfunction have also been described.PurposeOur study aimed to compare the sensitivities of various clinical, biochemical and echocardiographic criteria used to diagnosis HFpEF on a cohort of admitted HFpEF patients. Methods: This was a single-center retrospective review of inpatients with a primary diagnosis of HFpEF over a 2-year period. Electronic medical records were reviewed to analyze patient demographics, medical comorbidities and laboratory results. Echocardiograms were reviewed to analyze left ventricular mass, left atrial volume index and tricuspid regurgitation jet velocity as well as parameters of diastology to determine H2FPEF, HFA-PEFF scores, and American Society of Echocardiography diastolic dysfunction (ASE-DD) grading. Sensitivities for various diagnostic criteria were compared. A subgroup analysis was performed for different cut-offs of E/e' septal velocities. Student's T test was performed for continuous data and statistical significant was defined as p<0.05.ResultsOver a 2 year period, 325 patients admitted with a primary diagnosis of HFpEF were analyzed. The average patient age was 80.2 years and 197 patients were female (60.6%). Brain natriuretic peptide (BNP) great than 100 pg/ml had the highest sensitivity of 94%. ASE-DD criteria for diastolic dysfunction had a sensitivity of 58%. H2FPEF risk percentage of ≥90% had sensitivity of 63%. Septal E/e' of ≥15 had a sensitivity of 57% which increased to 90% when cut-off was lowered to ≥10. In a subgroup analysis of E/e' <12 or ≥12, patients with E/e' ≥12 had significantly higher H2FPEF score, HFA-PEFF score and length of stay (p<0.05). Average E/e' also had a positive correlation to percent change in BNP from baseline (R=0.83) and admission BNP (R=0.62).ConclusionOur study shows that current diagnostic criteria for HFpEF have relatively low sensitivity. Specifically, echocardiographic criteria may be too strict and a lower E/e' cutoff may improve diagnostic sensitivity. The correlation of E/e' and BNP suggests a relationship between the functional and biochemical entities of HFpEF. Further studies to optimize HFpEF diagnostic criteria are desired.

GW29-e0856 Optimal Status Markers for Heart Failure with Preserved Ejection Fraction

GW28-e0756 New and Definitive Marker Confirming the Optimal Status in the Treatment of Heart Failure with Preserved Ejection Fraction

GW28-e0772 the Enlarged Size of the Femoral Vein is More Accurate in the Prognostication of Patients with Asymptomatic Heart Failure

GW29-e0845 Differences in Physical Examination of Patients with Symptomatic and Asymptomatic Fluid Overload and Low Ejection Fraction

GW28-e0752 Update on New Simple Imaging Test Identifying Correctly the Heart Failure Patients Who Do Not Need In-patient Admission or Will Have Short Hospital Stay if Admitted

Measuring the Size and Expansion of the Common Femoral Vein As A New Method of Detection and Stratification of Heart Failure

Analysis Of Clinical, Biochemical And Echocardiographic Criteria For Heart Failure With Preserved Ejection Fraction

Biomarkers of heart failure with normal ejection fraction: a systematic review

A Novel Three-Dimensional and Tissue Doppler Echocardiographic Index for Diagnosing and Prognosticating Heart Failure with Preserved Ejection Fraction

GW28-e0776 Three Year Follow-Up of Patients with Left Ventricular Dysfunction Causing Ischemia and Patent Coronary Arteries

Left atrial ejection force as a marker for the diagnosis of heart failure with preserved ejection fraction

Novel Strategies in Diagnosing Heart Failure with Preserved Ejection Fraction: A Comprehensive Literature Review

Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study

Heart Failure With Preserved Ejection Fraction: A Review

A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction

The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review

Evaluation of the diagnostic accuracy of current biomarkers in heart failure with preserved ejection fraction: A systematic review and meta-analysis

Treatment Of Heart Failure With Mid-Range Ejection Fraction: A Summary Of Current Evidence

Diagnostic and prognostic value of an ejection fraction adjusted for myocardial remodeling

Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping

Echocardiographic predictors of cardiovascular outcome in heart failure with preserved ejection fraction